Press Releases

Shilpa CDMO*, a dedicated complex small-molecule contract development and manufacturing organisation will launch next month at CPHI Milan. The new brand, separate from parent company Shilpa Medicare, provides a specialist development and commercial manufacturing partner for biotech and pharma...

• Strong first-half momentum with sales up 7% year-on-year to EUR 883 million; Pharma business drives Group growth, with sales up by 14%, outpacing market growth • Adjusted EBITDA rises 16% to EUR 148 million; EBITDA margin expands by 130...

State-of-the-art customer center for the pharmaceutical and nutraceutical industries Customer focus, innovation, and growth under one roof Close collaboration between customer center and production for even faster time-to-market of new drugs and nutraceuticals Stuttgart (Germany), September 1, 2026. Syntegon,...

New global brand creates a stronger platform for innovation, partnerships and growth At the SSIEM Annual Symposium in Helsinki, Galen Ltd and POA Pharma announced the launch of Galsana, a new global brand for their metabolic product portfolio, bringing together...

Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organisation (CDMO) with strong scientific and manufacturing expertise, has partnered with the University of Sussex on a new Knowledge Transfer Partnership (KTP) that will use advanced data analytics and predictive modelling...

Syntegon completes its coater portfolio with new Sepion 75 Flexible batch processing, scalable process conditions, and containment-oriented design combined with closed material handling Consistent process principles enable direct parameter transfer from pilot to commercial scale as well as...

Proprietary training dataset spanning 300,000 cells and ~100 compounds positions DeepCyte to transform preclinical toxicology with mechanism-based prediction DeepCyte Inc., a techbio company building AI toxicology tools for drug development, today announced the launch of DeeTox Atlas™, the world's first...